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doi:10.1016/j.jfma.2011.07.003This review summarizes the results of epidemiological studies focusing on the detrimental
effects of home environmental factors on asthma morbidity in adults. We reviewed the liter-
ature on indoor air quality (IAQ), physical and sociodemographic factors, and asthma morbidity
in homes, and identified commonly reported asthma, allergic, and respiratory symptoms
involving the home environment. Reported IAQ and asthma morbidity data strongly indicated
positive associations between indoor air pollution and adverse health effects in most studies.
Indoor factors most consistently associated with asthma and asthma-related symptoms in
adults included fuel combustion, mold growth, and environmental tobacco smoke. Environ-
mental exposure may increase an adult’s risk of developing asthma and also may increase
the risk of asthma exacerbations. Evaluation of present IAQ levels, exposure characteristics,
and the role of exposure to these factors in relation to asthma morbidity is important for
improving our understanding, identifying the burden, and for developing and implementing
interventions aimed at reducing asthma morbidity.
Copyright ª 2011, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Exposure or sensitization to indoor pollutants, including
cigarette smoke,1 air pollution,2 and allergens,3 are
important risk factors for asthma morbidity. Although themy (Z.M. Isa).
ight ª 2011, Elsevier Taiwan LLCrole of indoor environmental exposure in the development
of asthma morbidity and exacerbations is largely unknown,
strong evidence suggests that exposure to indoor risk
factors plays a key role in triggering and exacerbating
asthma, allergic, and respiratory symptoms.
Many studies have examined the association between
exposure to indoor factors and asthma, allergic and respi-
ratory symptom among children in school and daycare
environments.4e6 However, adults can be exposed to indoor& Formosan Medical Association. All rights reserved.
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settings. Evidence suggests that many houses or occupa-
tional settings in China7 and other countries8e11 pose
significant and serious indoor environmental problems,
because adults spend as much as 90% of their lives in these
environments.12
Although a number of individual studies of indoor air
quality (IAQ), exposure characteristics, and the role of
these exposures in relation to asthma morbidity in homes or
occupational settings have been performed, a comprehen-
sive examination of the existing studies has not been
compiled. This review therefore aims to summarize the
results of epidemiological studies focusing on the detri-
mental effects of indoor environmental factors on asthma
morbidity in adults. We summarize the key findings from
the recent scientific literature, identify the most commonly
reported asthma morbidities involving home environments,
evaluate the key indoor aero contaminants most likely
to be related to asthma morbidity [e.g. nitrogen dioxide
(NO2), volatile organic compounds (VOCs), and biological
contaminants], and discuss the role of these exposures in
relation to asthma morbidity and the extent to which these
exposures affect asthma morbidity and severity.
Study selection
Scientific studies published in journals, conference
proceedings, and dissertations, since 1999 were searched
using a number of electronic databases, including PubMed,
MEDLINE, Proquest Health & Medical Complete and confer-
ence proceedings. Relevant studies were identified using
the following key words: “Indoor air pollution AND asthma”,
“Epidemiologic studies AND asthma”, “Indoor air pollutant
AND asthma and adult”, and “Indoor air pollution AND
asthma odds ratio (OR) allergy OR respiratory symptom AND
adult”. All retrieved abstracts were read initially to judge
the suitability of the studies. The full texts of the selected
references were then retrieved and saved. A total of 162
articles were assessed, of which 72 were finally used in this
review.
Chemical contaminants
Environmental tobacco smoke
Environmental tobacco smoke (ETS) is a dynamic, complex
mixture of more than 4000 chemicals found in both vapor
and particle phases.13 The 2006 US Surgeon General’s
report states that ETS is a cause of premature mortality.
Living with a smoker is associated with an estimated
20e30% increased risk of lung cancer.14 Exposure to ETS is
common in adults and has also been associated with an
increased risk of asthma morbidity.
Very few measurements of ETS in home settings have
been reported in the scientific literature.15,16 In a cohort
study in the US, Eisner et al found that ETS levels varied
between different settings.16 The detectable level of 7-day
median nicotine concentration was 0.03 mg/m3. Measured
nicotine concentrations were the highest among the
persons who reported home exposure (median 0.61 mg/m3),followed by work exposure (0.03 mg/m3), outdoor exposure
(0.025 mg/m3), and no exposure (0 mg/m3; p Z 0.03). In
another study, Eisner et al15 noted that higher levels of
second hand smoke exposure, as measured by the personal
nicotine badge, were related to greater asthma severity;
the second and third tertiles of hair nicotine exposure
were associated with a greater risk of hospital admission
for asthma [hazard ratio (HR) 3.73; 95% confidence inter-
vals (CI) 1.04e13.30 and HR 3.61; 95% CI 1.0e12.9,
respectively].
The effects of ETS on asthma morbidity have been inves-
tigated in variety of publications,1,17e24 and the evidence
indicates that adults who are exposed to ETS have a greater
risk of developing asthma. In a large study conducted among
3471 residents in Copenhagen, Denmark, aged 18e69 years,
Hersoug et al1 found that persons exposed to ETS for >5 h/d
were at increased risk of wheeze, chronic cough, and
decreased lung function [forced expiratory volume (FEV)1%
predicted]. In another study, also by Hersoug et al,17 expo-
sure to ETS for 0.5e5 hours was associated with an increased
prevalence of rhinitis symptoms, compared with exposure
for less than 0.5 hours. Gupta et al20 reported an OR of 1.22
(CI, 1.08e1.38) for an asthma attack in persons exposed to
ETS in India.
A recent French study investigated the relationship
between smoking and fraction of exhaled nitric oxide
(FeNO) levels in relation to the present asthma and atopy
status in 654 adults (268 asthmatic participants). Mean
FeNO values increased with asthma, atopy, and eosinophilia
(p < 0.001), and decreased with smoking. ETS exposure of
at least 2 h/d and active smoking were negatively associ-
ated with the FeNO levels in nonasthmatic participants
(p < 0.001) and asthmatic participants (p Z 0.02).19
Exposure to ETS was recently studied together with other
potential asthma risk factors in several studies.22,25e27 One
cross-sectional study from Taiwan explored the relative and
overall contributions of parental atopy and environmental
exposures to adulthood asthma among 24,784 participants.
Home exposure (OR, 1.80; 95% CI, 1.08e3.23; and pop-
ulation attributable risk, 28.04%) and parental atopy (OR,
4.47; 95% CI, 3.47e5.75; and percent attributable risk,
31.38%) were associated with new-onset asthma in adults.25
In Liaoling, in a heavy-industry province of northeastern
China, 31,704 adults from six cities were studied. Exposure
to smoking (OR, 2.06e5.02), occupational dust (OR,
1.35e1.72), occupational gas (OR, 1.48e1.72), and pres-
ence of irritating smoke during cooking (OR, 1.54e2.22)
were closely related to persistent cough, persistent phlegm
and wheeze, as well as to asthma.22Coal and biomass fuels
Stoves fueled by coal or biomass, which are major sources
of indoor combustion, release respiratory irritants such as
particulate matter (PM), carbon monoxide (CO), sulfur
dioxide, NO2, and organic toxins. Burning biomass fuels,
mainly wood, crop residues, and livestock dung, remain as
the important source of exposure to a variety of toxins.
According to some estimates, half of the world’s population
still uses coal or biomass for heating and cooking, most of
who live in developing countries, such as China.28
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and biomass fuel combustion could be present in environ-
ments. In a rural agricultural area of Tibet, China, the daily
average PM2.5 concentrations in the kitchen, living room,
bedroom, and yard were 134.91 mg/m3, 103.61 mg/m3,
76.13 mg/m3, and 78.33 mg/m3, respectively. Furthermore,
the PM2.5 concentrations in kitchens burning dung cake,
fuel wood, and methane were 117.41 mg/m3, 271.11 mg/m3,
and 46.96 mg/m3, respectively,29 with measured PM2.5
concentrations far in excess of the United States Environ-
mental Protection Agency’s30 standards for 24-hour average
PM2.5 of 65 mg/m
3.
Six articles were identified in scientific journals that
reported associations between coal and biomass fuel
combustion and asthma morbidity in households.9,31e35
Indoor combustion of coal and biomass fuels has been
found to affect the development and exacerbation of
asthma. In the US, 508 adults aged 40 years participated
in a study that evaluated indoor usage of biomass fuels,
using spirometry to assess participants’ lung function.
Participants exposed to cooking indoors with wood or coal
for 6 months had an OR of 2.3 (1.1e5.0) for reporting
current asthma, whereas no effect was found for heating
indoors with wood or coal (OR, 0.8; CI, 0.4e1.8).9
The relationship between cooking smoke exposures and
asthma was also examined in India’s Second National Family
Health Survey, which was a cross-sectional study (n Z
38,595) of a representative sample of elderly persons (60
years old) in India.32 Those exposed to biomass fuels were
compared with elderly people in homes using cleaner fuels.
Exposure to combustion of biomass fuels was associated
with a higher prevalence of asthma (OR, 1.59; 95% CI,
1.30e1.94). In Finland, Kilpela¨inen et al33 investigated the
impact of exposure to wood stove heating on subsequent
asthma in childhood among 10,667 university students aged
18e25 years. They found a significant negative association
between childhood wood stove heating and allergic rhinitis
or conjunctivitis in a univariate model (OR, 0.61; 95% CI,
0.61e0.91).
Although asthma is less prevalent among rural pop-
ulations where biomass fuels are in common use, compared
with their urban counterparts, it should not be assumed
that smoke exposure is not deleterious in these areas. A
cross-sectional study of disadvantaged women in rural
Nepal found significant associations between biomass-
smoke use and cough, phlegm, breathlessness, wheezing
symptoms, and asthma (p < 0.05).36 The prevalence of
respiratory illnesses was higher in those living in mud and
brick houses compared with those in concrete houses, and
was therefore higher in people living in the hills and in rural
areas, compared with those in flatter and urban areas.36 A
survey of cooking fuels and health status in China, per-
formed by Peabody et al37 reported that, in contrast to
other fuel types, coal was associated with negative impacts
on exhaled CO level, forced vital capacity (FVC), and life-
time prevalence of chronic obstructive pulmonary disease,
as well as asthma, in rural households.
In contrast to other studies, one home study from the US
found no association between gas stove use and FEV1, FVC
or peak expiratory flow, or risk of self-reported cough,
wheeze or other respiratory symptoms.38Nitrogen dioxide
NO2 is a major pollutant produced by combustion, and the
major source of exposure is from household appliances
fueled by gas, kerosene heaters, coal- and wood-burning
stoves, and tobacco smoking. Previous studies indicated
that indoor NO2 exposure might increase bronchial reac-
tivity in asthma patients and increase respiratory infections
among the general population.39,40
Two journal articles reported NO2 measurements in
houses. Simoni et al41 reported median NO2 levels of 20 ppb
in winter and 14 ppb in summer; the highest levels occurred
in the kitchen in the winter (33 ppb) and summer (20 ppb) in
Italian houses. Gilbert et al42 reported NO2 measurements
from 96 homes in Quebec City, Canada and found concen-
trations ranging from 3.3e29.1 mg/m3 [geometric mean (GM)
8.3 mg/m3].
Behavioral and sociodemographic factors in homes and
workplaces may have significant impacts on personal
exposures to NO2. In a cross-sectional study (n Z 176) of
randomly selected inhabitants (25e55 years old) in Finland,
factors significantly associated with differences in expo-
sures to NO2 were home and work location, housing char-
acteristics, traffic volume near home, season, keeping
windows open at home, and ETS exposure, as well as the
use of a gas stove.43
Women with mild-to-severe persistent asthma have
been reported in communities exposed to indoor gas
cooking in Singapore.44 In this study, the frequency of
cooking during a 2-week period was positively correlated
with mean exposure to NO2 (r Z 0.529; p Z 0.042), which
was associated with a greater use of rescue bronchodilators
(r Z 0.597; p Z 0.031), whereas it was negatively associ-
ated with peak expiratory flow rate variability (rZ e0.512;
p Z 0.051) and respiratory symptom severity score
(rZ e0.567; pZ 0.043), probably because of the masking
effects of bronchodilator treatment.
Although there is increasing evidence that NO2 may play
a role in the pathogenesis of asthma, the underlying
mechanisms are not clear. Bayram et al45 observed that NO2
modulated airway inflammation in asthma patients by
increasing the release of inflammatory mediators from
bronchial epithelial cells. Another study demonstrated that
NO2 was a proinflammatory air pollutant under the condi-
tions of repeated exposure, and found that repeated
exposure attenuated the changes in FEV1 and FVC after
initial exposure in healthy non-smoking adults.40Carbon monoxide
CO is an asphyxiant, and is known to bind to hemoglobin
and interfere with the transport of oxygen. Certain
vulnerable populations (e.g. the elderly people, fetuses,
and asthmatic people) are particularly sensitive to
elevated CO levels. The main indoor sources of CO are gas
stoves, furnaces, wood stoves and fireplaces, and ciga-
rette smoking, as well as vehicle exhaust from attached
garages.
High levels of CO in homes are closely related to unclean
fuel combustion (e.g. biomass fuels) used for heating or
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areas of Costa Rica; when a wood-burning stove was used,
average CO concentrations were between 0.5 ppm and
3.3 ppm. Naeher et al48 measured CO during breakfast,
lunch, and dinner in three high-density and four low-density
villages in Guatemala. The highest indoor concentrations of
CO were observed in homes using open fires (mean,
22.9 ppm and standard deviation, 28.1 ppm), reaching
a maximum of>250 ppm, which is far in excess of the United
States Environmental Protection Agency’s30 8-hour average
CO standard of 9 ppm or 10 mg/m3.
Remarkably few studies to date have evaluated the
relationship between indoor CO exposure and asthma
morbidity among adults in households.49,50 In China, Pan
et al50 observed harmful effects of CO levels on pulmonary
function in farmers in Anhui Province, China.Volatile organic compounds
The World Health Organization’s51 definition of VOCs
includes all organic compounds (substances made up of
predominantly carbon and hydrogen) with boiling tempera-
tures in the range of 50e260C, excluding pesticides. VOCs,
toxic gases or vapors emitted at room temperature from
certain solids or liquids, involve a variety of chemicals [e.g.
formaldehyde (FA), benzene, and perchloroethylene], some
of which may have acute or/and chronic adverse effects.
Cigarette smoke, cleaners, floor/wall coverings, paints, and
room deodorizers are major sources of indoor VOCs.
Three articles were found in scientific journals with
reported measurements of VOCs.52e54 Arif and Shah54
reported VOC measurements in households in the US
where the GM concentration varied from as low as
0.03 mg/m3 for trichloroethene to as high as 14.33 mg/m3 for
toluene. Levels of indoor toluene measured in Erfurt and
Hamburg in Germany were 37.3 mg/m3 and 20.5 mg/m3,
respectively, with a significant difference in levels between
the two cities (p < 0.0001).53 Hodgson and Levin52 assessed
the VOC levels in indoor air in North America and reported
that average indoor concentrations of some toxic air
contaminants such as 1,1,1-trichloroethane have decreased
since 1990.
Acute symptoms resulting from the indoor VOC exposure
have been reported, including eye and upper respiratory
irritation, rhinitis, wheezing, breathlessness, and asthma.
Several previous studies have identified relationships
between various health outcomes among adults and the
indoor VOC exposure. In the US, 550 participants exposed to
10 VOCs collected as part of the National Health and
Nutrition Examination Survey 1999e2000 were studied.54
Adults exposed to aromatic compounds had ORs of 1.63
(95% CI, 1.17e2.27) for doctor-diagnosed asthma, and 1.68
(95% CI, 1.08e2.61) for wheezing attacks.
Various VOCs are known to have adverse effects on
pulmonary health, but most studies have reported the
impacts of individual VOCs, instead of taking account of
their combined effects on health.54,55 In a recent study in
France, 1012 inhabitants (aged 15 years) from 490
dwellings were quantitatively evaluated by an IAQ Obser-
vatory. Among the adults, asthma (8.6%) was significantly
associated with N-undecane and 1,2,4-trimethylbenzenelevels, and rhinitis (38.3%) was associated with ethyl-
benzene, trichloroethylene, and m/p-and o-xylene. The
VOC levels in homes were associated with prevalence of
asthma and rhinitis in adults in concentration-dependent
manners.56
Formaldehyde
Acute exposure to FA is highly irritating to the eyes, nose,
and throat, resulting in coughing and wheezing symptoms.
Further exposure may induce severe allergic reactions of
the skin and respiratory tract.57 The World Health Organi-
zation’s recommended maximum level for FA in indoor
environments is 100 mg/m3 in 30 minutes.
Six publications measured FA in houses.42,58e61 Guo
et al58 reported that the 24-hour average FA concentrations
in 37 homes exceeded the good class of the Hong Kong IAQ
Objectives (<100 mg/m3). Indoor FA and styrene levels in
Hong Kong were higher than in other East Asian cities,
reflecting the fact that homes in Hong Kong were more
affected by household products and materials. FA levels
were also measured in another study of 96 homes in Quebec
City, Canada. The GM FA concentration for these house-
holds was 29.5 mg/m3, ranging from 9.6e90.0 mg/m3.42
Hodgson et al59 measured FA concentrations in four
newly-built houses for a period of 2e9.5 months after
completion in North America. FA concentrations were
below or near 50 ppb with a GM value for all houses of
40 ppb. Weng et al reported a mean concentration of total
carbonyl compounds in residential indoor air in Hangzhou,
China of 222.6 mg/m3 in summer, which was higher than in
winter (68.5 mg/m3). Multiple regression analysis indicated
that carbonyl concentrations in air depend on the age of
the decorations and furniture, as well as on their concen-
trations in outdoor air.61
Several studies focused on the relationship between
higher indoor concentrations of FA and asthma morbidity,
and produced controversial results.62e64 Matsunaga et al62
studied 998 pregnant women in Osaka, Japan and found
that exposure to FA of 47 ppb was positively associated
with an increased prevalence of atopic eczema (OR, 2.25;
95% CI, 1.01e5.01), especially among women with a nega-
tive familial allergic history. In another study, Casset et al63
found that exposure to low levels of FA (<100 mg/m3)
significantly enhanced bronchial responsiveness to mite
allergen in mite-sensitized adult asthmatics.
An additional study, however, found no association
between FA exposure and asthma morbidity.64 In a double-
blind crossover study conducted in Paris, France, 12 adults
with intermittent asthma and allergy exposed to FA levels
as low as 500 mg/m3 showed no deleterious effects on
airway allergen responsiveness, whereas a trend toward
a protective effect was detected.
Biological contaminants
Numerous studies have shown that biological contaminants
can be present in the environment. Biological contaminants
are frequently detected in homes, but the levels of expo-
sure vary considerably. Biological reservoirs include dust
mites, molds and other fungi, bacteria, and human, pet and
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conditions, as well as microbial products such as endo-
toxins, microbial fragments, peptidoglycans, and various
allergens. The term “biological contaminants” usually
refers to a variety of agents from biological sources found
in indoor environments, including bacteria (including
endotoxins from bacteria) and fungi (which may contain
allergens, toxins, and irritants). Fungi and dampness or
mold are usually considered as risk factors for atopy in the
home environment.
Exposure to allergens from dust mites [Dermatophagoides
farinae 1 (D farinae 1), Dermatophagoides pteronyssinus
(D pteronyssinus)], cats [Felis domesticus 1 (F domesticus
1)], dogs [Canis familiaris 1 (C familiaris 1)], cockroaches
[Blattella germanica 1 (B germanica 1), B germanica 2
(B germanica 2)], and mice [Mus musculus 1 (M musculus 1),
Mouse urinary protein], as well as to molds in homes are
important risk factors for asthma development and exacer-
bations. Measured values of biological contaminants can vary
significantly depending on the sampling techniques and
analytical methods used. Antibody-based enzyme-linked
immunosorbent assays have been used to quantify allergen
concentrations in most scientific studies.
Indoor exposure to dust mite allergens
House dust mites (HDM) are notable sources of inhalant
allergens in many parts of the world. Several studies have
shown higher concentrations of HDM allergens in residential
environments.65e69 The reported range of cat and dog
allergens in house dust ranged from 0.11e24 mg/g. Tra-
kultivakorn et al measured HDM allergens (D pteronyssinus,
D farinae 1) in collected dust from mattresses and living
room floors from 35 Chiang Mai homes, and found GMs of
D pteronyssinus, D. farinae 1, and total Group I allergens in
dust from mattresses and living room floors of 8.61 mg/g,
2.88 mg/g, and 15.81 mg/g and 1.61 mg/g, 0.27 mg/g, and
2.43 mg/g, respectively.66
Gross et al67 subsequently reported that concentrations
of HDM allergens were significantly higher on lower floors
(2e8 times higher, D pteronyssinus, D farinae 1), in older
mattresses (3e13 times higher, D pteronyssinus, D farinae
1), in post-war buildings (6 times higher, D pteronyssinus),
in houses without central heating (2 times higher, D pter-
onyssinus), in old carpets (3 times higher, D pteronyssinus),
and when there was a dog in the house (3 times higher,
D farinae 1). Nam et al,69 however, reported lower
D pteronyssinus levels for floors and mattresses, with GMs
of 0.11 mg/g (range: 0.01e4.05) and 0.14 mg/g (range:
0.01e30.0), respectively. Corresponding levels of D farinae
1 were higher, at 7.46 mg/g (range: 0.01e262.9) and
10.2 mg/g (range: 0.01e230.9) for floors and mattresses,
respectively. Furthermore, Su et al68 reported that 65% of
selected mattresses in Taiwan had D pteronyssinus levels
above 2 mg/g. Most airborne fungal concentrations found in
homes were higher than the recommended levels.
Indoor exposure to cat and dog allergens
Cats and dogs are the most popular pets in most parts of
world, but keeping these animals at home is associatedwith a high prevalence of allergic sensitization. Four studies
measured cat and dog allergens in home environ-
ments,65,70e72 and elevated levels of C familiaris 1 and F
domesticus 1 were detected in both dust and air samples.
Allergen levels showed high variability between houses,
with a reported range of 0.1e200 mg/g.
Arbes et al71 measured allergens in dust collected from
beds, bedrooms floors, living room floors, and living room
sofas from 831 US homes. C familiaris 1 and F domesticus 1
were detected in 100% and 99.9% of homes, respectively;
though only 49.1% of homes had resident animals. Averaged
over the sampled sites, GM concentrations (mg/g) were 4.69
for C familiaris 1 and 4.73 for F domesticus 1. Among homes
with an indoor dog or cat, GM concentrations were 69 mg/g
for C familiaris 1 and 200 mg/g for F domesticus 1,
respectively. Among the homes with no indoor pet, GM
concentrations were >1.0 mg/g.
In theUS, floor dust in houseswas analyzed for cat and dog
allergens, which ranged from <0.002 ng/m3 to >5 ng/m3.
Airborne endotoxin levels were significantly lower in homes
with a cat, compared with homes with a dog (p< 0.001), and
were significantly correlated with airborne Can f 1 (rZ 0.50,
p < 0.01), but not Fel d 1.72 In another study, dog allergen
concentrations were higher in homes with dogs compared
with those without dogs. Mean concentrations of cat allergen
were 0.1 mg/g.65
Indoor exposure to cockroach and mouse allergens
Cockroach and mouse allergens are ubiquitous in many
homes at levels that might contribute to asthma morbidity.
Previous studies have examined cockroach and rodent
allergen levels in residential environments. GM concen-
trations of mouse allergens varied from 0.94.6 mg/g in
a US study.73 In another study, detectable levels of mouse
allergen were found in 82% of US homes (n Z 831), and
kitchen floor concentrations exceed 1.6 mg/g.74 Elevated
cockroach allergen levels have also been detected in
cities in the US74,75 and some other countries.76,77 A
recent study demonstrated that cockroaches were found
in 77% of 324 apartments and apartments with high B
germanica 2 levels had a 1.7-fold increased OR for having
an asthmatic resident (95% CI, 1.2e2.3).75 Furthermore,
in a Chinese study, cockroach allergens were detected in
93% of households (n Z 107) and were higher in living
room samples compared with bedding samples. Cock-
roach allergen levels were higher during winter than in
summer.76
Indoor exposure to fungal allergens
Fungal allergen levels are generally higher in settled
house dust. Exposure to fungal allergens has usually been
estimated using fungal culture methods. One study
examined indoor fungal spore levels in houses in Mexico,78
and the most frequently cultured fungi were Cladospo-
rium spp. (76%), Alternaria spp. (57.5%) and Aspergillus
spp. (51.3%), whereas another study in Iran identified
Cladosporium spp. (29.2%), Aspergillus spp. (19.0%), and
Penicillium spp. (18.3%) as the most common indoor
fungi.79
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Asthma morbidity is highly prevalent in both urban and
rural areas, and its prevalence has been closely related to
bacterial endotoxins. In the United States, Roy et al80
quantified bacterial DNA and endotoxin contents in dust
from various geographic locations. The highest bacterial
DNA levels were measured in farm barns (mean, 22.1 mg/g
dust), followed by rural homes (6.3 mg/g), and farm homes
(2.2 mg/g) and urban homes (0.6 mg/g), respectively. Bis-
chof et al81 measured endotoxin concentrations in settled
house dust collected from 405 randomly selected homes in
two German cities. The mean concentration of 2.274 mg
endotoxin/g dust in living rooms was about two orders of
magnitude below mean occupational exposure. Endotoxin
concentrations were higher in older buildings (means ratio,
1.52, 95% CI, 1.14e2.04), and in the lower story of the
dwelling (means ratio, 1.30, 95% CI, 1.04e1.62).Relationships between asthma and asthma-related
symptoms and exposure to indoor biological
contaminants in homes
Numerous studies have shown that indoor allergens
are causally related to asthma and asthma-related
symptoms.26,80,82e90 Biological contaminant exposure has
clear implications for sensitization and clinical asthma
through the development of bronchial hyper-responsiveness
and airway inflammation in sensitized subjects. Because
people in modern society spend most of their time in resi-
dential environments, homes may be important sources of
indoor biological contaminant exposure. Indeed allergen
levels in homes, which include a variety of potential
allergen reservoirs (e.g. bedding, mattresses, carpeting,
and upholstered furniture), may be higher than in occupa-
tional settings.
Numerous studies have reported that exposure of
sensitized asthmatics to high levels of allergens caused
worsening of pulmonary function.82e84 A recent study found
that many asthma triggers (specifically mold) were as
prevalent or more so in the homes of New Yorkers with
asthma, compared with control households. A direct asso-
ciation was identified among the presence of mold
(adjusted OR, 2.5; 95% CI, 1.8e3.4), air cleaners (adjusted
OR, 2.2; 95% CI, 1.7e2.8), humidifiers (adjusted OR, 1.4;
95% CI, 1.1e1.8), and current asthma.88 Another study in
the United Kingdom demonstrated that adults both sensi-
tized and exposed to high levels of sensitizing allergens had
significantly lower predicted FEV1% (mean, 83.7% vs. 89.3%;
p Z 0.03), higher FeNO values (GM, 12.8 ppb vs. 8.7 ppb;
p Z 0.001), and more severe airway reactivity (PD20 GM,
0.25 mg vs. 0.73 mg; p < 0.001) compared with unsensitized
and unexposed individuals.89 A recent Swedish study
examined if exposure to indoor allergens was associated
with allergic sensitization prevalence. The study identified
a positive association between asthma symptoms and cat
allergen levels (OR, 1.53; 95% CI, 1.04e2.24), whereas
levels of viable molds were significantly associated with
increased bronchial responsiveness. The lower prevalence
of allergic sensitization in Reykjavı´k may be partly relatedto lower indoor allergen exposure.10 However, a cohort
study (n Z 245) in New York found no association between
sensitization to indoor allergens and increased asthma
morbidity in inner-city adults.90
It is possible that the farming environment and rural
lifestyle might be associated with an unknown “protective
farming” effect in terms of prevalence of asthma
morbidity.80,86,87 In a study of Norwegian farmers, farmers
had lower risks of allergic rhinitis, atopic sensitization,
and sensitization against pollen and mites (ORs: 0.63;
0.86; 0.51; and 0.80, respectively) compared with urban
residents. Exposure to endotoxins and fungal spores
appears to have a protective effect against atopic asthma,
but not nonatopic asthma, in farmers.86 Roy et al80 repor-
ted that DNA from farm barn dust augmented the immu-
nomodulatory effects of endotoxin and may, together with
other microbial components, mitigate allergy and asthma
development.
Several studies have suggested that poor IAQ caused by
moisture (or dampness) and mold problems, might be
related to asthma morbidity among adults.26,84,85 A recent
meta-analysis examined the association between indoor
dampness and mold contamination and adverse health
effects. Building dampness and mold were associated with
increases of approximately 30e50% in a variety of respi-
ratory and asthma-related health outcomes.26 Another
study in Canada found that the prevalence of chronic
wheeze, wheeze with shortness of breath, and allergy
were higher in women who exposed to damp housing
compared with those without exposure to damp housing
(p < 0.05).85
Although previous studies suggest that exposure to aer-
oallergens in homes may significantly affect pulmonary
health, the underlying mechanisms responsible for the
observed health effects are not well understood.Summary and conclusions
Exposure to indoor aero contaminants in residential envi-
ronments is common. Available measurements of indoor
pollutants in homes suggest that asthma-related indoor
pollution exists in many homes. A review of the literature
shows that levels of aero contaminants vary greatly in
terms of physical (e.g. temperature and humidity), struc-
tural (e.g. housing quality) and behavioral factors (e.g.
cleaning, smoking, and pet holding). It is clear that indoor
aero contaminants are potent triggers of asthma and
asthma-related symptoms in homes. Numerous studies
of indoor environments generally suggest a relationship
between exposure to indoor aero contaminants and asthma
morbidity in adults. The levels of indoor aero contaminants
from coal and biomass combustion, microbes, and tobacco
use exceeded exposure thresholds in most studies and
were associated with asthma morbidity. These indoor risk
factors suggest that some measures should be put in place
to reduce asthma morbidity in the adult population.
A variety of studies have strongly suggested that wide-
spread environmental inadequacies in homes present
potential risk factors for asthma and asthma-related symp-
toms among adults. Home environments might thus be
Do indoor environments influence asthma and asthma-related symptoms? 561major sources of aero contaminants in terms of adult indoor
exposure. Further studies are therefore needed to deter-
mine the indoor environmental aero contaminant load in
homes and its effect on adults.Acknowledgments
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